Table 1 General demographic and clinics characteristics in Diabetics

Number (%)

68 (60.70)

67 (58.90)

Age (years)

59.91 ± 10.08

60.91 ± 10.08

Males n (%)

43 (63.20)

42 (62.68)

Years of evolution

5.41 ± 4.19

6.41 ± 4.19

Smokers n (%)

16 (23.50)

16(25.00)

Ischemic heart disease n (%)

8 (11.80)

8 (12.50)

Cerebrovascular disease n (%)

2 (2.90)

2(2.50)

BMI (kg/m²)

30.08 ± 4.96

29.71 ± 5.28

-0.39

-0.69

to

-0.08

0.014

Waist circumference (cm)

102.93 ± 12.73

101.63 ± 13.74

-1.30

-2.08

to

0.11

0.078

Total Cholesterol (mg/dL)

187.54 ± 33.97

185.84 ± 37.10

-1.70

-10.36

to

5.43

0.534

Tryglicerides (mg/dL)

143.90 ± 68.25

141.63 ± 76.03

-2.24

-14.90

to

13.62

0.929

LDL cholesterol (mg/dL)

108.61 ± 28.45

107.95 ± 28.91

-0.66

-8.33

to

5.28

0.656

HDL cholesterol (mg/dL)

48.61 ± 11.69

48.48 ± 12.09

-0.13

-2.06

to

1.52

0.764

Serum glucose (mg/dL)

126.68 ± 35.34

132.48 ± 45.81

5.80

-0.45

to

14.54

0.065

HbA1c (%)

6.83 ± 1.17

7.01 ± 1.33

0.18

-0.07

to

0.41

0.159

Serum creatinine, (mg/dL)

0.86 ± 0.17

0.86 ± 0.21

0.00

-0.04

to

0.04

1.000

hs-c-reactive (mg/dL)

0.34 ± 0.51

0.32 ± 0.42

-0.02

-0.17

to

0.10

0.631

Fibrinogen (mg/dL)

337.16 ± 61.16

365.82 ± 93.23

26.66

6.18

to

54.28

0.015

HOMA-IR

3.24 ± 2.69

3.34 ± 3.82

1.00

-0.38

to

1.24

0.287

Office SBP (mm Hg)

136.13 ± 19.09

132.44 ± 18.80

-3.69

-8.16

to

1.16

0.139

Office DBP (mm Hg)

82.64 ± 11.59

78.92 ± 9.82

-3.72

-6.08

to

-1.10

0.005

Office PP, mm Hg

53.88 ± 14.38

54.69 ± 17.64

0.81

-2.65

to

4.27

0.640

Office HR

72.10 ± 12.43

70.56 ± 11.06

-1.54

-2.81

to

1.36

0.488

Mean Antihypertensive Drugs

1.51 ± 1.15

1.57 ± 1.21

0.06

-0.17

to

0.28

0.603

Antihypertensive Drugs, n (%)

52 (76.50)

51(75.00)

-1.5

-1.4

to

1.5

0.625

Mean Lipid lowering drugs

0.68 ± 0.56

0.66 ± 0.56

-0.01

-0.10

to

0.07

0.742

Lipid lowering drugs, n (%)

45 (66.20)

44(64.70)

-1.5

-1.8

to

1.6

0.687